<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Endocrinol (Lausanne)</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Endocrinol (Lausanne)</journal-id>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Endocrinology</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32322239</article-id>
<article-id pub-id-type="pmc">7156634</article-id>
<article-id pub-id-type="doi">10.3389/fendo.2020.00186</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Anxiolytic and Anxiogenic? How the Transcription Factor MEF2 Might Explain the Manifold Behavioral Effects of Oxytocin</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Jurek</surname>
<given-names>Benjamin</given-names>
</name>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/547274/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Meyer</surname>
<given-names>Magdalena</given-names>
</name>
<uri xlink:href="http://loop.frontiersin.org/people/920103/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff><institution>Department of Behavioural and Molecular Neurobiology, Institute of Zoology, University of Regensburg</institution>, <addr-line>Regensburg</addr-line>, <country>Germany</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Heather K. Caldwell, Kent State University, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Brian Trainor, University of California, Davis, United States; Ben Nephew, Worcester Polytechnic Institute, United States</p>
</fn>
<corresp id="c001">*Correspondence: Benjamin Jurek <email>benjamin.jurek@ur.de</email></corresp>
<fn fn-type="other" id="fn001">
<p>This article was submitted to Neuroendocrine Science, a section of the journal Frontiers in Endocrinology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>4</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>11</volume>
<elocation-id>186</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>1</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>3</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2020 Jurek and Meyer.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Jurek and Meyer</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>The neuromodulator oxytocin, since its first synthesis by du Vigneaud in 1953, has mainly been associated with beneficial physiological effects, as well as positive social and emotional behaviors. This overall positive picture of oxytocin as the “love-, cuddle-, or bonding-hormone” has repeatedly been challenged since then. Oxytocin-induced effects that would be perceived as negative by the individual, such as increased anxiety or potentiation of stress-induced ACTH release, as well as the regulation of negative approach-related emotions, such as envy and schadenfreude (gloating) have been described. The general consent is that oxytocin, instead of acting unidirectional, induces changes in the salience network to shift the emphasis of emotional contexts, and therefore can, e.g., produce both anxiolytic as well as anxiogenic behavioral outcomes. However, the underlying mechanisms leading to alterations in the salience network are still unclear. With the aim to understand the manifold effects of oxytocin on a cellular/molecular level, a set of oxytocin receptor-coupled signaling cascades and downstream effectors regulating transcription and translation has been identified. Those oxytocin-driven effectors, such as MEF2 and CREB, are known modulators of the neuronal and glial cytoarchitecture. We hypothesize that, by determining cellular morphology and connectivity, MEF2 is one of the key factors that might contribute to the diverse behavioral effects of oxytocin.</p>
</abstract>
<kwd-group>
<kwd>oxytocin</kwd>
<kwd>salience</kwd>
<kwd>MEF2</kwd>
<kwd>anxiety</kwd>
<kwd>stress</kwd>
<kwd>cellular morphology</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Deutsche Forschungsgemeinschaft<named-content content-type="fundref-id">10.13039/501100001659</named-content></funding-source>
<award-id rid="cn001">GRK2174</award-id>
<award-id rid="cn001">JU3039/1-1</award-id>
<award-id rid="cn001">Ne465/27-1</award-id>
<award-id rid="cn001">Ne465/31-1</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="87"></ref-count>
<page-count count="7"></page-count>
<word-count count="5906"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>The neuropeptide oxytocin is mainly produced in the hypothalamic paraventricular (PVN) and supraoptic nuclei (SON), it is released from magnocellular cells by axonal and somatodendritic release, and into the periphery via axonal projections (<xref ref-type="bibr" rid="B1">1</xref>). Peripheral axonal release into the blood stream and central dendritic release can occur in an orchestrated or independent manner (<xref ref-type="bibr" rid="B2">2</xref>–<xref ref-type="bibr" rid="B4">4</xref>) and produces a variety of behavioral effects, ranging from anxiety, fear conditioning and fear extinction, social exploration and recognition to aggressive behavior (<xref ref-type="bibr" rid="B5">5</xref>). After taking differences in dosing, timing, species, or central vs. peripheral release into account, we are still left with some puzzling inconsistencies regarding the behavioral effects of oxytocin [for review see (<xref ref-type="bibr" rid="B1">1</xref>)]. The concept to explain and interpret the behavioral effects of oxytocin is centered around a change in salience of emotional contexts (<xref ref-type="bibr" rid="B6">6</xref>–<xref ref-type="bibr" rid="B8">8</xref>), rather than unidirectional influences on certain types of behavior (e.g., anxiety). Our aim is to establish a coherent mechanistic understanding of the intracellular processes that underlie this change in emotional salience and therefore the effects on opposing behavioral outcomes.</p>
</sec>
<sec id="s2">
<title>Alleviating Behavioral Effects of Oxytocin</title>
<p>In rodents, the level of anxiety can be assessed by testing the exploratory drive vs. the fear of open and brightly lit spaces, as it is done in the elevated plus maze (EPM) or Light Dark Box (LDB). In previous publications, we have established that an infusion of synthetic oxytocin directly into the PVN of male and female rats reduces anxiety-like behavior for at least 4 h, i.e., increases the time spent in the open arms or lit compartment of the EPM and LDB, respectively (<xref ref-type="bibr" rid="B9">9</xref>–<xref ref-type="bibr" rid="B12">12</xref>). The endogenous release of oxytocin within the PVN can be triggered in male and female rats by various stimuli (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>). For instance, mating leads to a similar anxiolysis as observed with synthetic oxytocin infusions, indicating the behavioral valence of synthetic oxytocin (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). In female prairie voles, intra-PVN infusions of oxytocin reduce anxiety-like behavior by activating local GABAergic neurons, which dampen the stress-induced activity of CRF-positive neurons and subsequent corticosterone release (<xref ref-type="bibr" rid="B17">17</xref>). As oxytocin receptors are also expressed on CRF-positive neurons (<xref ref-type="bibr" rid="B18">18</xref>), it not only acts via GABAergic inhibition, but also relies on direct oxytocin receptor-coupled modulation of stress-induced CRF transcription in the PVN of male rats as well (<xref ref-type="bibr" rid="B19">19</xref>). The interplay between oxytocin and the CRF system is not restricted to the PVN, as oxytocin receptor interneurons in the medial prefrontal cortex are responsible for anxiolysis in male mice, whereas in female mice they act pro-social by GABAergic inhibition of CRF receptor 1 expressing neurons (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>).</p>
<p>In a similar manner, infusions into the central amygdala reduce anxiety as well (<xref ref-type="bibr" rid="B22">22</xref>), and evoked release of endogenous oxytocin attenuates freezing in fear-conditioned mice (<xref ref-type="bibr" rid="B23">23</xref>) by acting on a local GABAergic inhibitory output circuit (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>). The type of fear response displayed, i.e., either startle response or active escape, is orchestrated by glutamatergic projections from the basolateral amygdala to oxytocin receptor positive cells in the central amygdala of mice and humans (<xref ref-type="bibr" rid="B26">26</xref>). Oxytocin also attenuates social fear expression in male, virgin and lactating female mice (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>), and cued fear extinction in male mice (<xref ref-type="bibr" rid="B29">29</xref>).</p>
<p>Those positive “dampening” or “alleviating” effects of oxytocin have been well-established in literature, so much, that a comprehensive list of all studies would be beyond the scope of this review [for extended discussion see (<xref ref-type="bibr" rid="B1">1</xref>)]. However, not all findings are in line with such a “positive” image of oxytocin. Depending on the context, oxytocin can produce opposing, more adverse or negative effects on behavior.</p>
</sec>
<sec id="s3">
<title>Adverse Behavioral Effects of Oxytocin</title>
<p>However, well-described the alleviating effects of oxytocin might be, potentiating effects of oxytocin on the stress response and increased anxiety have to be reflected to generate a comprehensive understanding. For instance, when peripheral oxytocin levels are increased chronically by subcutaneous infusion in male rats over the course of 14 days, ACTH and corticosterone levels, and adrenal weights are increased, indicating a potentiating effect of oxytocin on the HPA axis, and therefore the stress response (<xref ref-type="bibr" rid="B30">30</xref>). In addition, single subcutaneous injections transiently increase plasma ACTH and corticosterone levels in male rats (<xref ref-type="bibr" rid="B31">31</xref>), but decrease corticosterone levels 6 h after the injection without affecting ACTH levels. In an <italic>ex vivo</italic> setting, i.e., isolated hemipituitaries from male rats, oxytocin potentiated the CRF-induced ACTH release (<xref ref-type="bibr" rid="B32">32</xref>). In an <italic>in vivo</italic> setting, peripheral oxytocin secretion is modestly influenced by the activated HPA axis, i.e., plasma corticosterone levels; however, corticosterone levels amplified stress-induced oxytocin release within the PVN (<xref ref-type="bibr" rid="B33">33</xref>). Those data delineate oxytocin as a modulator of activated systems like the HPA axis instead of acting as a solitary driving force. However, a recent study conducted in wild chimpanzees failed to associate oxytocinergic system activity with increased stress and aggression during out-group conflict (<xref ref-type="bibr" rid="B34">34</xref>), which is seemingly in contrast to predictions made by the social salience hypothesis of oxytocin. However, whether urinary oxytocin and cortisol levels reflect central or plasma concentrations has yet to be determined, as a random discrepancy between those body-fluids might be the cause for the failed association.</p>
<p>In addition, timing and dosage seem to be key aspects that orchestrate the functional outcome. For instance, in a mouse model of chronic oxytocin infusion via osmotic minipumps, a low dose of chronic oxytocin (1 ng/0.2 μl/h) alleviated the effects of chronic stress, such as thymus atrophy, adrenal hypertrophy and decreased <italic>in vitro</italic> adrenal ACTH sensitivity; whereas a high dose (10 ng/0.2 μl/h) increased anxiety-like behavior in male mice (<xref ref-type="bibr" rid="B35">35</xref>). The increased anxiety was concomitant with a decreased expression of oxytocin receptors in the septum, likely as part of a negative feedback regulation, indicating this region as one important regulatory region for oxytocin-driven anxiety. However, the expression of fear in socially defeated male mice is positively associated with the expression level of oxytocin receptors and its coupling to the MAP kinase pathway in the lateral septum (<xref ref-type="bibr" rid="B36">36</xref>). When knocked down, the level of fear displayed by socially defeated mice toward their defeater was diminished, compared to mice where oxytocin receptors were overexpressed. The authors conclude that oxytocin does not have a unidirectional influence on anxiety, but rather changes the salience or valence of an emotional context (<xref ref-type="bibr" rid="B36">36</xref>). Another study revealed a full rescue of socially transmitted fear in unfamiliar male mice together with an enhanced cellular activity within the anterior cingulate cortex after acute intranasal oxytocin administration (<xref ref-type="bibr" rid="B37">37</xref>). To the contrary, the same study also investigated the effects of chronic oxytocin administration, which led to long-term facilitation of observational fear. Interestingly, none of these manipulations affected fear acquired as a result of direct experience with the stressor, but only socially transmitted fear. Hence, these results emphasize the role of oxytocin in context-dependent empathy.</p>
<p>Effects on empathy and context-dependent social cues have also been studied in human probands that received intranasal oxytocin. Those studies found increased aggression toward game partners in the “social orientation paradigm” (<xref ref-type="bibr" rid="B38">38</xref>), increased envy and schadenfreude or gloating in a game of chance (<xref ref-type="bibr" rid="B39">39</xref>), and even increased anxiety, indicated by an enhanced startle response after unpredictable threats (<xref ref-type="bibr" rid="B40">40</xref>).</p>
<p>Most of the above-mentioned studies interpret their data according to the salience hypothesis stating that oxytocin increases the perception of social stimuli dependent on the context, instead of acting unidirectional on any behavior. Thus, if oxytocin is not a pure anxiolytic, analgesic, or anti-stress hormone, but rather shifts the salience of an emotional context, changes in the activity of the salience network must be detectable (see <xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Graphical Abstract of the proposed signaling scheme. Oxytocin binds its receptor, which transactivates different types of calcium channels, leading to calcium influx from the extracellular space. Calcium activates protein kinase C, and subsequent MAPK pathway activation, i.e., MEK1/2-ERK1/2, which translocates to the nucleus and activates the transcription factor CREB. Calcium also activates the calcium-dependent phosphatase calcineurin, which dephosphorylates and therefore activates MEF2. Active MEF2 increases gene transcription of negative regulators of synaptic structures, causing decreased neurite outgrowth, synapse number, and hypoconnectivity between neighboring neurons. As oxytocin receptor positive neurons are located within brain regions of the salience network, MEF2 activity regulates the connectivity within those regions, dampening or increasing the activity in the whole network. Depending on the emotional context of external stimuli, those changes in the salience network can cause alleviating or adverse behavioral responses. The schematic art pieces used in this figure were provided by Servier Medical art (<ext-link ext-link-type="uri" xlink:href="http://servier.com/Powerpoint-image-bank">http://servier.com/Powerpoint-image-bank</ext-link>). Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.0 Unported License.</p>
</caption>
<graphic xlink:href="fendo-11-00186-g0001"></graphic>
</fig>
</sec>
<sec id="s4">
<title>Oxytocin and the Salience Network</title>
<p>In order to understand the multitude of behavioral effects of oxytocin, a theoretical framework has been proposed that includes a prominent role for oxytocin-dopamine-interactions in regulating the salience of social cues (<xref ref-type="bibr" rid="B41">41</xref>). For instance, a recent study conducted in titi monkeys found increased anxiety and a trend toward increased glucose uptake in regions of the salience network. Specifically, glucose uptake tended to increase in the SON and caudate nucleus, in male animals treated chronically with intranasal oxytocin from 12 to 18 months of age (<xref ref-type="bibr" rid="B42">42</xref>). In addition to the SON and caudate nucleus, the salience network consists of other brain regions that have already been associated with oxytocinergic effects and that express the oxytocin receptor, like the anterior cingulate cortex, lateral septum, striatum, medial prefrontal cortex, hippocampus, amygdala, nucleus accumbens, and PVN (<xref ref-type="bibr" rid="B42">42</xref>). The significance of the salience network for psychiatric disorders has been shown by a very comprehensive meta-analysis that included more than 7,000 individuals with psychiatric diagnoses ranging from depression, bipolar disorder, schizophrenia, or obsessive-compulsive disorder, to anxiety disorders (<xref ref-type="bibr" rid="B43">43</xref>). In each of those disorders, changes in myelin protein expression (<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B45">45</xref>), decreased gray and white matter volume (<xref ref-type="bibr" rid="B46">46</xref>), and loss of connectivity have been detected in core regions of the salience network, like the anterior cingulate cortex or medial prefrontal cortex, leading to impairments of cognitive control, which has been proposed as a diagnostic feature across the above-mentioned psychiatric disorders (<xref ref-type="bibr" rid="B47">47</xref>).</p>
<p>Besides alterations in oligodendrocyte-based myelin formation or damage, reduced gray matter volume and connectivity can be caused either by morphological changes of neurons (i.e., increased or decreased synapse formation) or by reduced neuronal survival rates. Consequentially, factors that influence those two aspects, and are triggered by oxytocin could be the sought after molecular substrates of the behavioral effects of oxytocin. In search for those factors, we investigated the signaling cascades coupled to the oxytocin receptor.</p>
</sec>
<sec id="s5">
<title>Oxytocin and MEF2</title>
<p>A first clue can be drawn from the apparent universal involvement of the MAP kinase pathway in the above-described contexts, e.g., the fear enhancing effects in the lateral septum (<xref ref-type="bibr" rid="B36">36</xref>), or the anxiolytic and anti-stress effects in the PVN (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B19">19</xref>). Potential targets of the MEK1/2-ERK1/2 pathway are on the one hand the transcription factor CREB, which is involved in oxytocin-induced spatial memory formation (<xref ref-type="bibr" rid="B48">48</xref>) and CRF gene transcription (<xref ref-type="bibr" rid="B19">19</xref>). On the other hand, the transcription factor myocyte enhancer factor 2 (MEF2), which has been shown to be directly activated following oxytocin receptor activation (<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>) via the calcium-dependent phosphatase calcineurin (<xref ref-type="bibr" rid="B51">51</xref>). MEF2 is a main regulator of neuronal morphology, survival, connectivity, plasticity, and metaplasticity (<xref ref-type="bibr" rid="B52">52</xref>–<xref ref-type="bibr" rid="B54">54</xref>). CREB and MEF2 can act independently, but have also been shown to bind in concert to the synaptic response element (SARE), an enhancer sequence found upstream of many neuronal plasticity-related genes (<xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B56">56</xref>). While we have identified a MEF2 binding sequence in the oxytocin receptor promoter with <italic>in silico</italic> prediction tools, there is no recent evidence available, whether activated MEF2 alters the transcription of the <italic>Oxtr</italic> gene. Decreased MEF2 levels and increased phosphorylation levels, i.e., decreased gene transcription, have been found in mice that underwent fear conditioning and spatial memory tasks. In contrast, increasing MEF2 levels and dephosphorylation prevented the formation of spatial memory and associated increase in spine density. These findings suggest that MEF2-mediated transcription constrains memory formation by interfering with neuronal plasticity (<xref ref-type="bibr" rid="B57">57</xref>).</p>
</sec>
<sec id="s6">
<title>MEF2 and Neuronal Connectivity</title>
<p>Neuronal plasticity and connectivity is governed by the ability of the neurons to adapt their cellular morphology to the momentary requirements, i.e., induce neurite outgrowth and retraction. Both factors, CREB and MEF2 have been shown to actively regulate neurite outgrowth (<xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B59">59</xref>) and thus influence the formation of synapses (<xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B61">61</xref>). Those oxytocin-induced cellular effects can depend on MEF2 expression levels as the transcription factor is known to be a regulator of metaplasticity, i.e., it determines how neurons respond to stimuli by shifting plasticity thresholds (<xref ref-type="bibr" rid="B54">54</xref>). Moreover, mutated MEF2 has been associated with Rett-like syndrome (<xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B63">63</xref>) and autism spectrum disorder (<xref ref-type="bibr" rid="B64">64</xref>–<xref ref-type="bibr" rid="B66">66</xref>). Recent publications indicate a connection between dysregulated synapse number, i.e., hyperconnectivity, and symptoms of autism spectrum disorder (<xref ref-type="bibr" rid="B67">67</xref>); moreover, lower plasma oxytocin levels have been reported in children with autism and social impairments (<xref ref-type="bibr" rid="B68">68</xref>, <xref ref-type="bibr" rid="B69">69</xref>). Those impairments and low plasma oxytocin levels might be associated with an altered composition of the gut microbiome (<xref ref-type="bibr" rid="B70">70</xref>), a process that also impacts MEF2 phosphorylation (<xref ref-type="bibr" rid="B71">71</xref>), and neuronal plasticity (<xref ref-type="bibr" rid="B72">72</xref>). A current study revealed that in male patients with autism spectrum disorder higher levels of endogenous salivary oxytocin are associated with lower degrees of functional coupling between the amygdala and hippocampus (<xref ref-type="bibr" rid="B73">73</xref>). Notably, a single dose of intranasal oxytocin induced a further reduction in the degree of functional connectivity between those two regions. Those data suggest that abnormal oxytocin synthesis and/or intracerebral release could be the cause for the observed connectivity differences in autistic patients. In support of this hypothesis, we and others have recently shown that oxytocin modulates neuronal morphology and synapse formation in dependence of MEF2A, calcium signaling, and the MAPK pathway (<xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B74">74</xref>–<xref ref-type="bibr" rid="B78">78</xref>).</p>
</sec>
<sec id="s7">
<title>MEF2-Driven Mechanisms Affecting Neuronal Connectivity</title>
<p>In order to elucidate the underlying signaling pathways explaining the manifold behavioral effects of oxytocin, we have gathered evidence for a central role of the transcription factor MEF2. The activity-dependent influence on neuronal plasticity, termed metaplasticity, is one key characteristic trait of MEF2 (<xref ref-type="bibr" rid="B54">54</xref>, <xref ref-type="bibr" rid="B79">79</xref>), and could explain the multitude of behavioral effects of oxytocin, by altering the connectivity, and therefore activity, between neurons of brain regions that are part of the salience network (e.g., within the mPFC, hypothalamus, or amygdala). Altered activity within those oxytocin-sensitive brain regions dampens or stimulates adjacent regions (<xref ref-type="bibr" rid="B80">80</xref>, <xref ref-type="bibr" rid="B81">81</xref>), and therefore the whole network. The molecular machinery that determines MEF2 activity, and therefore causes this plasticity, has been investigated in detail. MEF2 contains several different phosphorylation sites, acting either inhibitory, or stimulatory on gene transcription (<xref ref-type="bibr" rid="B52">52</xref>). Two different calcium-dependent pathways have been described: (1) Class II HDACs are bound to MEF2, acting as permanent inhibitors. Upon calcium influx, these HDACs are phosphorylated by calcium/calmodulin activated kinase (CaMK) and exported out of the nucleus, relieving MEF2 repression and allowing for the activation of MEF2-dependent transcription (<xref ref-type="bibr" rid="B58">58</xref>). (2) Calcium influx leads to the dephosphorylation of MEF2 proteins at serine 408, via the calcium-dependent phosphatase calcineurin (<xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B82">82</xref>). This dephosphorylation promotes a switch from sumoylation to acetylation at lysine 403, which leads to inhibition of dendritic claw differentiation (<xref ref-type="bibr" rid="B82">82</xref>). The question remains how activated (acetylated and dephosphorylated) MEF2 regulates synapse number, and therefore connectivity between neurons. Several possible mechanisms have been described: first, activated MEF2 promotes the sumoylation and subsequent degradation of a synaptic scaffolding protein, the postsynaptic density protein 95 (PSD-95) (<xref ref-type="bibr" rid="B83">83</xref>). Second, the transcription of negative regulators of synapse development, arc and synGAP, is stimulated by activated MEF2, leading to a reduced excitatory synapse number in hippocampal neurons (<xref ref-type="bibr" rid="B60">60</xref>). And lastly, MEF2 closely interacts with another regulator of neuronal connectivity, the mitochondria (<xref ref-type="bibr" rid="B79">79</xref>). We have shown that MEF2 expression modulates the basic mitochondrial functions like maximal respiration, spare respiratory capacity, and ATP production in neurons by means of a CRISPR-Cas-generated MEF2A functional knockout cell line (<xref ref-type="bibr" rid="B51">51</xref>). Those mitochondrial mechanisms are known to regulate synaptic strength (<xref ref-type="bibr" rid="B79">79</xref>). Since mitochondria have their own genome, transcription factors like MEF2 are able to induce mitochondrial gene transcription in addition to nuclear transcription. Indeed, MEF2 promotes the expression of the mitochondrial gene ND6, which is essential for the function of the oxidative phosphorylation system (<xref ref-type="bibr" rid="B84">84</xref>), which regulates the production of ROS. Release of ROS activates the pro-apoptotic caspase-3, which induces the breakdown of PSD-95, thereby weakening synaptic strength (<xref ref-type="bibr" rid="B79">79</xref>).</p>
<p>Taken together, the above-described effects of MEF2 on synaptic strength can be bidirectional, as MEF2 can either stimulate or inhibit gene transcription (<xref ref-type="bibr" rid="B85">85</xref>). Oxytocin receptor signaling activates MEF2 in a context-dependent manner and thereby induces morphological changes, e.g., neurite retraction (<xref ref-type="bibr" rid="B50">50</xref>). Morphological changes in turn determine the synaptic strength and therefore connectivity between oxytocin receptor positive neurons (<xref ref-type="bibr" rid="B76">76</xref>). Oxytocin-sensitive neurons are located in brain regions that are part of the salience network (<xref ref-type="bibr" rid="B80">80</xref>), which has been shown to be responsive to oxytocin (<xref ref-type="bibr" rid="B42">42</xref>) and modulates anxiety-like behavior or the stress response (<xref ref-type="bibr" rid="B86">86</xref>, <xref ref-type="bibr" rid="B87">87</xref>).</p>
</sec>
<sec id="s8" sec-type="conclusions">
<title>Conclusion</title>
<p>In conclusion, oxytocin exerts its behavioral effects not in a direct manner, but rather acts modulatory on the activated salience network, to alter the emotional context of a secondary stimulus and produce a variety of context-dependent behavioral outcomes, including anxiolysis and anxiogenesis and increased or reduced stress response. We hypothesize that MEF2 is one of the key elements enabling this behavioral variability by modulating the connectivity of oxytocin receptor-positive neurons within a brain region and as result of this, potentially affecting the salience network as a whole.</p>
</sec>
<sec id="s9">
<title>Author Contributions</title>
<p>BJ and MM contributed equally to the manuscript.</p>
<sec>
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>We would like to thank Adam Smith, Valery Grinevich and Michael Bowen for their invitation to be part of the special issue The Oxytocin System in Fear, Stress, Anguish, and Pain. Furthermore, we thank Prof. Dr. Inga D. Neumann for critical proofreading.</p>
</ack>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> The manuscript was financially supported by grants of the Deutsche Forschungsgemeinschaft to Prof. Dr. Inga D. Neumann (Ne465/27-1, Ne465/31-1), BJ JU3039/1-1, and the DFG-GRK 2174.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurek</surname><given-names>B</given-names></name><name><surname>Neumann</surname><given-names>ID</given-names></name></person-group>. <article-title>The oxytocin receptor: from intracellular signaling to behavior</article-title>. <source/>Physiol Rev. (<year>2018</year>) <volume>98</volume>:<fpage>1805</fpage>–<lpage>908</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00031.2017</pub-id><pub-id pub-id-type="pmid">29897293</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludwig</surname><given-names>M</given-names></name><name><surname>Leng</surname><given-names>G</given-names></name></person-group>
<article-title>Dendritic peptide release and peptide-dependent behaviors</article-title>. <source/>Nat Rev Neurosci. (<year>2006</year>) <volume>7</volume>:<fpage>126</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1845</pub-id><pub-id pub-id-type="pmid">16429122</pub-id></mixed-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>ID</given-names></name></person-group>. <article-title>Stimuli and consequences of dendritic release of oxytocin within the brain</article-title>. <source/>Biochem Soc Trans. (<year>2007</year>) <volume>35</volume>(<issue>Pt 5</issue>):<fpage>1252</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1042/BST0351252</pub-id><pub-id pub-id-type="pmid">17956324</pub-id></mixed-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>ID</given-names></name><name><surname>Landgraf</surname><given-names>R</given-names></name></person-group>. <article-title>Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors</article-title>. <source/>Trends Neurosci. (<year>2012</year>) <volume>35</volume>:<fpage>649</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2012.08.004</pub-id><pub-id pub-id-type="pmid">22974560</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer-Lindenberg</surname><given-names>A</given-names></name><name><surname>Domes</surname><given-names>G</given-names></name><name><surname>Kirsch</surname><given-names>P</given-names></name><name><surname>Heinrichs</surname><given-names>M</given-names></name></person-group>. <article-title>Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine</article-title>. <source/>Nat Rev Neurosci. (<year>2011</year>) <volume>12</volume>:<fpage>524</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3044</pub-id><pub-id pub-id-type="pmid">21852800</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Simplicio</surname><given-names>M</given-names></name><name><surname>Massey-Chase</surname><given-names>R</given-names></name><name><surname>Cowen</surname><given-names>PJ</given-names></name><name><surname>Harmer</surname><given-names>CJ</given-names></name></person-group>. <article-title>Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers</article-title>. <source/>J Psychopharmacol. (<year>2009</year>) <volume>23</volume>:<fpage>241</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1177/0269881108095705</pub-id><pub-id pub-id-type="pmid">18801829</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quintana</surname><given-names>DS</given-names></name><name><surname>Westlye</surname><given-names>LT</given-names></name><name><surname>Hope</surname><given-names>S</given-names></name><name><surname>Naerland</surname><given-names>T</given-names></name><name><surname>Elvsashagen</surname><given-names>T</given-names></name><name><surname>Dorum</surname><given-names>E</given-names></name><etal></etal></person-group>. <article-title>Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial</article-title>. <source/>Transl Psychiatry. (<year>2017</year>) <volume>7</volume>:<fpage>e1136</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2017.103</pub-id><pub-id pub-id-type="pmid">28534875</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duque-Wilckens</surname><given-names>N</given-names></name><name><surname>Steinman</surname><given-names>MQ</given-names></name><name><surname>Busnelli</surname><given-names>M</given-names></name><name><surname>Chini</surname><given-names>B</given-names></name><name><surname>Yokoyama</surname><given-names>S</given-names></name><name><surname>Pham</surname><given-names>M</given-names></name><etal></etal></person-group>. <article-title>Oxytocin receptors in the anteromedial bed nucleus of the stria terminalis promote stress-induced social avoidance in female california mice</article-title>. <source/>Biol Psychiatry. (<year>2018</year>) <volume>83</volume>:<fpage>203</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2017.08.024</pub-id><pub-id pub-id-type="pmid">29066224</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blume</surname><given-names>A</given-names></name><name><surname>Bosch</surname><given-names>OJ</given-names></name><name><surname>Miklos</surname><given-names>S</given-names></name><name><surname>Torner</surname><given-names>L</given-names></name><name><surname>Wales</surname><given-names>L</given-names></name><name><surname>Waldherr</surname><given-names>M</given-names></name><etal></etal></person-group>. <article-title>Oxytocin reduces anxiety via ERK1/2 activation: local effect within the rat hypothalamic paraventricular nucleus</article-title>. <source/>Eur J Neurosci. (<year>2008</year>) <volume>27</volume>:<fpage>1947</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2008.06184.x</pub-id><pub-id pub-id-type="pmid">18412615</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurek</surname><given-names>B</given-names></name><name><surname>Slattery</surname><given-names>DA</given-names></name><name><surname>Maloumby</surname><given-names>R</given-names></name><name><surname>Hillerer</surname><given-names>K</given-names></name><name><surname>Koszinowski</surname><given-names>S</given-names></name><name><surname>Neumann</surname><given-names>ID</given-names></name><etal></etal></person-group>. <article-title>Differential contribution of hypothalamic MAPK activity to anxiety-like behaviour in virgin and lactating rats</article-title>. <source/>PLoS ONE. (<year>2012</year>) <volume>7</volume>:<fpage>e37060</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0037060</pub-id><pub-id pub-id-type="pmid">22615888</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Burg</surname><given-names>EH</given-names></name><name><surname>Stindl</surname><given-names>J</given-names></name><name><surname>Grund</surname><given-names>T</given-names></name><name><surname>Neumann</surname><given-names>ID</given-names></name><name><surname>Strauss</surname><given-names>O</given-names></name></person-group>. <article-title>Oxytocin stimulates extracellular Ca2+ influx through TRPV2 channels in hypothalamic neurons to exert its anxiolytic effects</article-title>. <source/>Neuropsychopharmacology. (<year>2015</year>) <volume>40</volume>:<fpage>2938</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2015.147</pub-id><pub-id pub-id-type="pmid">26013963</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinetz</surname><given-names>S</given-names></name><name><surname>Meinung</surname><given-names>CP</given-names></name><name><surname>Jurek</surname><given-names>B</given-names></name><name><surname>von Schack</surname><given-names>D</given-names></name><name><surname>van den Burg</surname><given-names>EH</given-names></name><name><surname>Slattery</surname><given-names>DA</given-names></name><etal></etal></person-group>. <article-title><italic>De Novo</italic> protein synthesis mediated by the eukaryotic elongation factor 2 is required for the anxiolytic effect of oxytocin</article-title>. <source/>Biol Psychiatry. (<year>2019</year>) <volume>85</volume>:<fpage>802</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2019.01.010</pub-id><pub-id pub-id-type="pmid">30826070</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landgraf</surname><given-names>R</given-names></name><name><surname>Neumann</surname><given-names>ID</given-names></name></person-group>. <article-title>Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication</article-title>. <source/>Front Neuroendocrinol. (<year>2004</year>) <volume>25</volume>:<fpage>150</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1016/j.yfrne.2004.05.001</pub-id><pub-id pub-id-type="pmid">15589267</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>ID</given-names></name></person-group>. <article-title>Brain oxytocin: a key regulator of emotional and social behaviours in both females and males</article-title>. <source/>J Neuroendocrinol. (<year>2008</year>) <volume>20</volume>:<fpage>858</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2826.2008.01726.x</pub-id><pub-id pub-id-type="pmid">18601710</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waldherr</surname><given-names>M</given-names></name><name><surname>Neumann</surname><given-names>ID</given-names></name></person-group>. <article-title>Centrally released oxytocin mediates mating-induced anxiolysis in male rats</article-title>. <source/>Proc Natl Acad Sci USA. (<year>2007</year>) <volume>104</volume>:<fpage>16681</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0705860104</pub-id><pub-id pub-id-type="pmid">17925443</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nyuyki</surname><given-names>KD</given-names></name><name><surname>Waldherr</surname><given-names>M</given-names></name><name><surname>Baeuml</surname><given-names>S</given-names></name><name><surname>Neumann</surname><given-names>ID</given-names></name></person-group>. <article-title>Yes, I am ready now: differential effects of paced versus unpaced mating on anxiety and central oxytocin release in female rats</article-title>. <source/>PLoS ONE. (<year>2011</year>) <volume>6</volume>:<fpage>e23599</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0023599</pub-id><pub-id pub-id-type="pmid">21858181</pub-id></mixed-citation>
</ref>
<ref id="B17">
<label>17.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>AS</given-names></name><name><surname>Tabbaa</surname><given-names>M</given-names></name><name><surname>Lei</surname><given-names>K</given-names></name><name><surname>Eastham</surname><given-names>P</given-names></name><name><surname>Butler</surname><given-names>MJ</given-names></name><name><surname>Linton</surname><given-names>L</given-names></name><etal></etal></person-group>. <article-title>Local oxytocin tempers anxiety by activating GABAA receptors in the hypothalamic paraventricular nucleus</article-title>. <source/>Psychoneuroendocrinology. (<year>2016</year>) <volume>63</volume>:<fpage>50</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2015.09.017</pub-id><pub-id pub-id-type="pmid">26415118</pub-id></mixed-citation>
</ref>
<ref id="B18">
<label>18.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dabrowska</surname><given-names>J</given-names></name><name><surname>Hazra</surname><given-names>R</given-names></name><name><surname>Guo</surname><given-names>JD</given-names></name><name><surname>Dewitt</surname><given-names>S</given-names></name><name><surname>Rainnie</surname><given-names>DG</given-names></name></person-group>
<article-title>Central CRF neurons are not created equal: phenotypic differences in CRF-containing neurons of the rat paraventricular hypothalamus and the bed nucleus of the stria terminalis</article-title>. <source/>Front Neurosci. (<year>2013</year>) <volume>7</volume>:<fpage>156</fpage>
<pub-id pub-id-type="doi">10.3389/fnins.2013.00156</pub-id><pub-id pub-id-type="pmid">24009552</pub-id></mixed-citation>
</ref>
<ref id="B19">
<label>19.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurek</surname><given-names>B</given-names></name><name><surname>Slattery</surname><given-names>DA</given-names></name><name><surname>Hiraoka</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Nishimori</surname><given-names>K</given-names></name><name><surname>Aguilera</surname><given-names>G</given-names></name><etal></etal></person-group>. <article-title>oxytocin regulates stress-induced Crf gene transcription through CREB-regulated transcription coactivator 3</article-title>. <source/>J Neurosci. (<year>2015</year>) <volume>35</volume>:<fpage>12248</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1345-14.2015</pub-id><pub-id pub-id-type="pmid">26338335</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakajima</surname><given-names>M</given-names></name><name><surname>Gorlich</surname><given-names>A</given-names></name><name><surname>Heintz</surname><given-names>N</given-names></name></person-group>. <article-title>Oxytocin modulates female sociosexual behavior through a specific class of prefrontal cortical interneurons</article-title>. <source/>Cell. (<year>2014</year>) <volume>159</volume>:<fpage>295</fpage>–<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.09.020</pub-id><pub-id pub-id-type="pmid">25303526</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Nakajima</surname><given-names>M</given-names></name><name><surname>Ibanez-Tallon</surname><given-names>I</given-names></name><name><surname>Heintz</surname><given-names>N</given-names></name></person-group>. <article-title>A cortical circuit for sexually dimorphic oxytocin-dependent anxiety behaviors</article-title>. <source/>Cell. (<year>2016</year>) <volume>167</volume>:<fpage>60</fpage>–<lpage>72 e11</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.08.067</pub-id><pub-id pub-id-type="pmid">27641503</pub-id></mixed-citation>
</ref>
<ref id="B22">
<label>22.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okimoto</surname><given-names>N</given-names></name><name><surname>Bosch</surname><given-names>OJ</given-names></name><name><surname>Slattery</surname><given-names>DA</given-names></name><name><surname>Pflaum</surname><given-names>K</given-names></name><name><surname>Matsushita</surname><given-names>H</given-names></name><name><surname>Wei</surname><given-names>FY</given-names></name><etal></etal></person-group>. <article-title>RGS2 mediates the anxiolytic effect of oxytocin</article-title>. <source/>Brain Res. (<year>2012</year>) <volume>1453</volume>:<fpage>26</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2012.03.012</pub-id><pub-id pub-id-type="pmid">22459044</pub-id></mixed-citation>
</ref>
<ref id="B23">
<label>23.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knobloch</surname><given-names>HS</given-names></name><name><surname>Charlet</surname><given-names>A</given-names></name><name><surname>Hoffmann</surname><given-names>LC</given-names></name><name><surname>Eliava</surname><given-names>M</given-names></name><name><surname>Khrulev</surname><given-names>S</given-names></name><name><surname>Cetin</surname><given-names>AH</given-names></name><etal></etal></person-group>. <article-title>Evoked axonal oxytocin release in the central amygdala attenuates fear response</article-title>. <source/>Neuron. (<year>2012</year>) <volume>73</volume>:<fpage>553</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.11.030</pub-id><pub-id pub-id-type="pmid">22325206</pub-id></mixed-citation>
</ref>
<ref id="B24">
<label>24.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname><given-names>D</given-names></name><name><surname>Veinante</surname><given-names>P</given-names></name><name><surname>Stoop</surname><given-names>R</given-names></name></person-group>. <article-title>Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala</article-title>. <source/>Science. (<year>2005</year>) <volume>308</volume>:<fpage>245</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1126/science.1105636</pub-id><pub-id pub-id-type="pmid">15821089</pub-id></mixed-citation>
</ref>
<ref id="B25">
<label>25.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viviani</surname><given-names>D</given-names></name><name><surname>Charlet</surname><given-names>A</given-names></name><name><surname>van den Burg</surname><given-names>E</given-names></name><name><surname>Robinet</surname><given-names>C</given-names></name><name><surname>Hurni</surname><given-names>N</given-names></name><name><surname>Abatis</surname><given-names>M</given-names></name><etal></etal></person-group>. <article-title>Oxytocin selectively gates fear responses through distinct outputs from the central amygdala</article-title>. <source/>Science. (<year>2011</year>) <volume>333</volume>:<fpage>104</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1126/science.1201043</pub-id><pub-id pub-id-type="pmid">21719680</pub-id></mixed-citation>
</ref>
<ref id="B26">
<label>26.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terburg</surname><given-names>D</given-names></name><name><surname>Scheggia</surname><given-names>D</given-names></name><name><surname>Triana Del Rio</surname><given-names>R</given-names></name><name><surname>Klumpers</surname><given-names>F</given-names></name><name><surname>Ciobanu</surname><given-names>AC</given-names></name><name><surname>Morgan</surname><given-names>B</given-names></name><etal></etal></person-group>. <article-title>The basolateral amygdala is essential for rapid escape: a human and rodent study</article-title>. <source/>Cell. (<year>2018</year>) <volume>175</volume>:<fpage>723</fpage>–<lpage>35 e716</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.09.028</pub-id><pub-id pub-id-type="pmid">30340041</pub-id></mixed-citation>
</ref>
<ref id="B27">
<label>27.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoicas</surname><given-names>I</given-names></name><name><surname>Slattery</surname><given-names>DA</given-names></name><name><surname>Neumann</surname><given-names>ID</given-names></name></person-group>. <article-title>Brain oxytocin in social fear conditioning and its extinction: involvement of the lateral septum</article-title>. <source/>Neuropsychopharmacology. (<year>2014</year>) <volume>39</volume>:<fpage>3027</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2014.156</pub-id><pub-id pub-id-type="pmid">24964815</pub-id></mixed-citation>
</ref>
<ref id="B28">
<label>28.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menon</surname><given-names>R</given-names></name><name><surname>Grund</surname><given-names>T</given-names></name><name><surname>Zoicas</surname><given-names>I</given-names></name><name><surname>Althammer</surname><given-names>F</given-names></name><name><surname>Fiedler</surname><given-names>D</given-names></name><name><surname>Biermeier</surname><given-names>V</given-names></name><etal></etal></person-group>. <article-title>Oxytocin signaling in the lateral septum prevents social fear during lactation</article-title>. <source/>Curr Biol. (<year>2018</year>) <volume>28</volume>:<fpage>1066</fpage>–<lpage>78 e1066</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2018.02.044</pub-id><pub-id pub-id-type="pmid">29551417</pub-id></mixed-citation>
</ref>
<ref id="B29">
<label>29.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toth</surname><given-names>I</given-names></name><name><surname>Neumann</surname><given-names>ID</given-names></name><name><surname>Slattery</surname><given-names>DA</given-names></name></person-group>. <article-title>Central administration of oxytocin receptor ligands affects cued fear extinction in rats and mice in a timepoint-dependent manner</article-title>. <source/>Psychopharmacology. (<year>2012</year>) <volume>223</volume>:<fpage>149</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-012-2702-4</pub-id><pub-id pub-id-type="pmid">22526533</pub-id></mixed-citation>
</ref>
<ref id="B30">
<label>30.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ondrejcakova</surname><given-names>M</given-names></name><name><surname>Bakos</surname><given-names>J</given-names></name><name><surname>Garafova</surname><given-names>A</given-names></name><name><surname>Kovacs</surname><given-names>L</given-names></name><name><surname>Kvetnansky</surname><given-names>R</given-names></name><name><surname>Jezova</surname><given-names>D</given-names></name></person-group>. <article-title>Neuroendocrine and cardiovascular parameters during simulation of stress-induced rise in circulating oxytocin in the rat</article-title>. <source/>Stress. (<year>2010</year>) <volume>13</volume>:<fpage>314</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.3109/10253891003596822</pub-id><pub-id pub-id-type="pmid">20536333</pub-id></mixed-citation>
</ref>
<ref id="B31">
<label>31.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersson</surname><given-names>M</given-names></name><name><surname>Hulting</surname><given-names>AL</given-names></name><name><surname>Uvnas-Moberg</surname><given-names>K</given-names></name></person-group>. <article-title>Oxytocin causes a sustained decrease in plasma levels of corticosterone in rats</article-title>. <source/>Neurosci Lett. (<year>1999</year>) <volume>264</volume>:<fpage>41</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/S0304-3940(99)00159-7</pub-id><pub-id pub-id-type="pmid">10320009</pub-id></mixed-citation>
</ref>
<ref id="B32">
<label>32.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbs</surname><given-names>DM</given-names></name><name><surname>Vale</surname><given-names>W</given-names></name><name><surname>Rivier</surname><given-names>J</given-names></name><name><surname>Yen</surname><given-names>SS</given-names></name></person-group>
<article-title>Oxytocin potentiates the ACTH-releasing activity of CRF(41) but not vasopressin</article-title>. <source/>Life Sci. (<year>1984</year>) <volume>34</volume>:<fpage>2245</fpage>–<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/0024-3205(84)90212-1</pub-id><pub-id pub-id-type="pmid">6328161</pub-id></mixed-citation>
</ref>
<ref id="B33">
<label>33.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torner</surname><given-names>L</given-names></name><name><surname>Plotsky</surname><given-names>PM</given-names></name><name><surname>Neumann</surname><given-names>ID</given-names></name><name><surname>de Jong</surname><given-names>TR</given-names></name></person-group>. <article-title>Forced swimming-induced oxytocin release into blood and brain: effects of adrenalectomy and corticosterone treatment</article-title>. <source/>Psychoneuroendocrinology. (<year>2017</year>) <volume>77</volume>:<fpage>165</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2016.12.006</pub-id><pub-id pub-id-type="pmid">28064086</pub-id></mixed-citation>
</ref>
<ref id="B34">
<label>34.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samuni</surname><given-names>L</given-names></name><name><surname>Preis</surname><given-names>A</given-names></name><name><surname>Deschner</surname><given-names>T</given-names></name><name><surname>Wittig</surname><given-names>RM</given-names></name><name><surname>Crockford</surname><given-names>C</given-names></name></person-group>. <article-title>Cortisol and oxytocin show independent activity during chimpanzee intergroup conflict</article-title>. <source/>Psychoneuroendocrinology. (<year>2019</year>) <volume>104</volume>:<fpage>165</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2019.02.007</pub-id><pub-id pub-id-type="pmid">30851601</pub-id></mixed-citation>
</ref>
<ref id="B35">
<label>35.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>S</given-names></name><name><surname>Slattery</surname><given-names>DA</given-names></name><name><surname>Uschold-Schmidt</surname><given-names>N</given-names></name><name><surname>Reber</surname><given-names>SO</given-names></name><name><surname>Neumann</surname><given-names>ID</given-names></name></person-group>. <article-title>Dose-dependent effects of chronic central infusion of oxytocin on anxiety, oxytocin receptor binding and stress-related parameters in mice</article-title>. <source/>Psychoneuroendocrinology. (<year>2014</year>) <volume>42</volume>:<fpage>225</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2014.01.021</pub-id><pub-id pub-id-type="pmid">24636519</pub-id></mixed-citation>
</ref>
<ref id="B36">
<label>36.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzman</surname><given-names>YF</given-names></name><name><surname>Tronson</surname><given-names>NC</given-names></name><name><surname>Jovasevic</surname><given-names>V</given-names></name><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Guedea</surname><given-names>AL</given-names></name><name><surname>Mizukami</surname><given-names>H</given-names></name><etal></etal></person-group>. <article-title>Fear-enhancing effects of septal oxytocin receptors</article-title>. <source/>Nat Neurosci. (<year>2013</year>) <volume>16</volume>:<fpage>1185</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3465</pub-id><pub-id pub-id-type="pmid">23872596</pub-id></mixed-citation>
</ref>
<ref id="B37">
<label>37.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pisansky</surname><given-names>MT</given-names></name><name><surname>Hanson</surname><given-names>LR</given-names></name><name><surname>Gottesman</surname><given-names>II</given-names></name><name><surname>Gewirtz</surname><given-names>JC</given-names></name></person-group>. <article-title>Oxytocin enhances observational fear in mice</article-title>. <source/>Nat Commun. (<year>2017</year>) <volume>8</volume>:<fpage>2102</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-017-02279-5</pub-id><pub-id pub-id-type="pmid">29235461</pub-id></mixed-citation>
</ref>
<ref id="B38">
<label>38.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ne‘eman</surname><given-names>R</given-names></name><name><surname>Perach-Barzilay</surname><given-names>N</given-names></name><name><surname>Fischer-Shofty</surname><given-names>M</given-names></name><name><surname>Atias</surname><given-names>A</given-names></name><name><surname>Shamay-Tsoory</surname><given-names>SG</given-names></name></person-group>. <article-title>Intranasal administration of oxytocin increases human aggressive behavior</article-title>. <source/>Horm Behav. (<year>2016</year>) <volume>80</volume>:<fpage>125</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.yhbeh.2016.01.015</pub-id><pub-id pub-id-type="pmid">26862988</pub-id></mixed-citation>
</ref>
<ref id="B39">
<label>39.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shamay-Tsoory</surname><given-names>SG</given-names></name><name><surname>Fischer</surname><given-names>M</given-names></name><name><surname>Dvash</surname><given-names>J</given-names></name><name><surname>Harari</surname><given-names>H</given-names></name><name><surname>Perach-Bloom</surname><given-names>N</given-names></name><name><surname>Levkovitz</surname><given-names>Y</given-names></name></person-group>. <article-title>Intranasal administration of oxytocin increases envy and schadenfreude (gloating)</article-title>. <source/>Biol Psychiatry. (<year>2009</year>) <volume>66</volume>:<fpage>864</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2009.06.009</pub-id><pub-id pub-id-type="pmid">19640508</pub-id></mixed-citation>
</ref>
<ref id="B40">
<label>40.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grillon</surname><given-names>C</given-names></name><name><surname>Krimsky</surname><given-names>M</given-names></name><name><surname>Charney</surname><given-names>DR</given-names></name><name><surname>Vytal</surname><given-names>K</given-names></name><name><surname>Ernst</surname><given-names>M</given-names></name><name><surname>Cornwell</surname><given-names>B</given-names></name></person-group>. <article-title>Oxytocin increases anxiety to unpredictable threat</article-title>. <source/>Mol Psychiatry. (<year>2013</year>) <volume>18</volume>:<fpage>958</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2012.156</pub-id><pub-id pub-id-type="pmid">23147382</pub-id></mixed-citation>
</ref>
<ref id="B41">
<label>41.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shamay-Tsoory</surname><given-names>SG</given-names></name><name><surname>Abu-Akel</surname><given-names>A</given-names></name></person-group>. <article-title>The social salience hypothesis of oxytocin</article-title>. <source/>Biol Psychiatry. (<year>2016</year>) <volume>79</volume>:<fpage>194</fpage>–<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2015.07.020</pub-id><pub-id pub-id-type="pmid">26321019</pub-id></mixed-citation>
</ref>
<ref id="B42">
<label>42.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arias Del Razo</surname><given-names>R</given-names></name><name><surname>Berger</surname><given-names>T</given-names></name><name><surname>Conley</surname><given-names>AJ</given-names></name><name><surname>Freeman</surname><given-names>SM</given-names></name><name><surname>Goetze</surname><given-names>LR</given-names></name><name><surname>Jacob</surname><given-names>S</given-names></name><etal></etal></person-group>. <article-title>Effects of chronic intranasal oxytocin on behavior and cerebral glucose uptake in juvenile titi monkeys</article-title>. <source/>Psychoneuroendocrinology. (<year>2019</year>) <volume>113</volume>:<fpage>104494</fpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2019.104494</pub-id><pub-id pub-id-type="pmid">31862614</pub-id></mixed-citation>
</ref>
<ref id="B43">
<label>43.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodkind</surname><given-names>M</given-names></name><name><surname>Eickhoff</surname><given-names>SB</given-names></name><name><surname>Oathes</surname><given-names>DJ</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Chang</surname><given-names>A</given-names></name><name><surname>Jones-Hagata</surname><given-names>LB</given-names></name><etal></etal></person-group>. <article-title>Identification of a common neurobiological substrate for mental illness</article-title>. <source/>JAMA Psychiatry. (<year>2015</year>) <volume>72</volume>:<fpage>305</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.2206</pub-id><pub-id pub-id-type="pmid">25651064</pub-id></mixed-citation>
</ref>
<ref id="B44">
<label>44.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honer</surname><given-names>WG</given-names></name><name><surname>Falkai</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Arango</surname><given-names>V</given-names></name><name><surname>Mann</surname><given-names>JJ</given-names></name><name><surname>Dwork</surname><given-names>AJ</given-names></name></person-group>. <article-title>Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness</article-title>. <source/>Neuroscience. (<year>1999</year>) <volume>91</volume>:<fpage>1247</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/S0306-4522(98)00679-4</pub-id><pub-id pub-id-type="pmid">10391432</pub-id></mixed-citation>
</ref>
<ref id="B45">
<label>45.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nave</surname><given-names>KA</given-names></name><name><surname>Ehrenreich</surname><given-names>H</given-names></name></person-group>. <article-title>Myelination and oligodendrocyte functions in psychiatric diseases</article-title>. <source/>JAMA Psychiatry. (<year>2014</year>) <volume>71</volume>:<fpage>582</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.189</pub-id><pub-id pub-id-type="pmid">24671770</pub-id></mixed-citation>
</ref>
<ref id="B46">
<label>46.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakhtiari</surname><given-names>R</given-names></name><name><surname>Zurcher</surname><given-names>NR</given-names></name><name><surname>Rogier</surname><given-names>O</given-names></name><name><surname>Russo</surname><given-names>B</given-names></name><name><surname>Hippolyte</surname><given-names>L</given-names></name><name><surname>Granziera</surname><given-names>C</given-names></name><etal></etal></person-group>. <article-title>Differences in white matter reflect atypical developmental trajectory in autism: A Tract-based Spatial Statistics study</article-title>. <source/>Neuroimage Clin. (<year>2012</year>) <volume>1</volume>:<fpage>48</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.nicl.2012.09.001</pub-id><pub-id pub-id-type="pmid">24179736</pub-id></mixed-citation>
</ref>
<ref id="B47">
<label>47.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>SK</given-names></name><name><surname>Dunlop</surname><given-names>K</given-names></name><name><surname>Downar</surname><given-names>J</given-names></name></person-group>. <article-title>Cortico-striatal-thalamic loop circuits of the salience network: a central pathway in psychiatric disease and treatment</article-title>. <source/>Front Syst Neurosci. (<year>2016</year>) <volume>10</volume>:<fpage>104</fpage>. <pub-id pub-id-type="doi">10.3389/fnsys.2016.00104</pub-id><pub-id pub-id-type="pmid">28082874</pub-id></mixed-citation>
</ref>
<ref id="B48">
<label>48.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomizawa</surname><given-names>K</given-names></name><name><surname>Iga</surname><given-names>N</given-names></name><name><surname>Lu</surname><given-names>YF</given-names></name><name><surname>Moriwaki</surname><given-names>A</given-names></name><name><surname>Matsushita</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>ST</given-names></name><etal></etal></person-group>. <article-title>Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade</article-title>. <source/>Nat Neurosci. (<year>2003</year>) <volume>6</volume>:<fpage>384</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1038/nn1023</pub-id><pub-id pub-id-type="pmid">12598900</pub-id></mixed-citation>
</ref>
<ref id="B49">
<label>49.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devost</surname><given-names>D</given-names></name><name><surname>Wrzal</surname><given-names>P</given-names></name><name><surname>Zingg</surname><given-names>HH</given-names></name></person-group>. <article-title>Oxytocin receptor signalling</article-title>. <source/>Prog Brain Res. (<year>2008</year>) <volume>170</volume>:<fpage>167</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1016/S0079-6123(08)00415-9</pub-id><pub-id pub-id-type="pmid">18655881</pub-id></mixed-citation>
</ref>
<ref id="B50">
<label>50.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>M</given-names></name><name><surname>Berger</surname><given-names>I</given-names></name><name><surname>Winter</surname><given-names>J</given-names></name><name><surname>Jurek</surname><given-names>B</given-names></name></person-group>. <article-title>Oxytocin alters the morphology of hypothalamic neurons via the transcription factor myocyte enhancer factor 2A (MEF-2A)</article-title>. <source/>Mol Cell Endocrinol. (<year>2018</year>) <volume>477</volume>:<fpage>156</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2018.06.013</pub-id><pub-id pub-id-type="pmid">29928931</pub-id></mixed-citation>
</ref>
<ref id="B51">
<label>51.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>M</given-names></name><name><surname>Kuffner</surname><given-names>K</given-names></name><name><surname>Winter</surname><given-names>J</given-names></name><name><surname>Neumann</surname><given-names>ID</given-names></name><name><surname>Wetzel</surname><given-names>CH</given-names></name><name><surname>Jurek</surname><given-names>B</given-names></name></person-group>. <article-title>Myocyte enhancer factor 2A (MEF2A) defines oxytocin-induced morphological effects and regulates mitochondrial function in neurons</article-title>. <source/>Int J Mol Sci. (<year>2020</year>) <volume>21</volume>:<fpage>2200</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21062200</pub-id><pub-id pub-id-type="pmid">32209973</pub-id></mixed-citation>
</ref>
<ref id="B52">
<label>52.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potthoff</surname><given-names>MJ</given-names></name><name><surname>Olson</surname><given-names>EN</given-names></name></person-group>. <article-title>MEF2: a central regulator of diverse developmental programs</article-title>. <source/>Development. (<year>2007</year>) <volume>134</volume>:<fpage>4131</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1242/dev.008367</pub-id><pub-id pub-id-type="pmid">17959722</pub-id></mixed-citation>
</ref>
<ref id="B53">
<label>53.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akhtar</surname><given-names>MW</given-names></name><name><surname>Kim</surname><given-names>MS</given-names></name><name><surname>Adachi</surname><given-names>M</given-names></name><name><surname>Morris</surname><given-names>MJ</given-names></name><name><surname>Qi</surname><given-names>X</given-names></name><name><surname>Richardson</surname><given-names>JA</given-names></name><etal></etal></person-group>. <article-title>In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival</article-title>. <source/>PLoS ONE. (<year>2012</year>) <volume>7</volume>:<fpage>e34863</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0034863</pub-id><pub-id pub-id-type="pmid">22496871</pub-id></mixed-citation>
</ref>
<ref id="B54">
<label>54.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>SX</given-names></name><name><surname>Cherry</surname><given-names>A</given-names></name><name><surname>Tari</surname><given-names>PK</given-names></name><name><surname>Podgorski</surname><given-names>K</given-names></name><name><surname>Kwong</surname><given-names>YK</given-names></name><name><surname>Haas</surname><given-names>K</given-names></name></person-group>. <article-title>The transcription factor MEF2 directs developmental visually driven functional and structural metaplasticity</article-title>. <source/>Cell. (<year>2012</year>) <volume>151</volume>:<fpage>41</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.08.028</pub-id><pub-id pub-id-type="pmid">23021214</pub-id></mixed-citation>
</ref>
<ref id="B55">
<label>55.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Tornos</surname><given-names>FM</given-names></name><name><surname>San Aniceto</surname><given-names>I</given-names></name><name><surname>Cubelos</surname><given-names>B</given-names></name><name><surname>Nieto</surname><given-names>M</given-names></name></person-group>. <article-title>Enrichment of conserved synaptic activity-responsive element in neuronal genes predicts a coordinated response of MEF2, CREB and SRF</article-title>. <source/>PLoS ONE. (<year>2013</year>) <volume>8</volume>:<fpage>e53848</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0053848</pub-id><pub-id pub-id-type="pmid">23382855</pub-id></mixed-citation>
</ref>
<ref id="B56">
<label>56.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pulimood</surname><given-names>NS</given-names></name><name><surname>Rodrigues</surname><given-names>WDSJ</given-names></name><name><surname>Atkinson</surname><given-names>DA</given-names></name><name><surname>Mooney</surname><given-names>SM</given-names></name><name><surname>Medina</surname><given-names>AE</given-names></name></person-group>. <article-title>The Role of CREB, SRF, and MEF2 in Activity-Dependent Neuronal Plasticity in the Visual Cortex</article-title>. <source/>J Neurosci. (<year>2017</year>) <volume>37</volume>:<fpage>6628</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0766-17.2017</pub-id><pub-id pub-id-type="pmid">28607167</pub-id></mixed-citation>
</ref>
<ref id="B57">
<label>57.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>CJ</given-names></name><name><surname>Mercaldo</surname><given-names>V</given-names></name><name><surname>Restivo</surname><given-names>L</given-names></name><name><surname>Yiu</surname><given-names>AP</given-names></name><name><surname>Sekeres</surname><given-names>MJ</given-names></name><name><surname>Han</surname><given-names>JH</given-names></name><etal></etal></person-group>. <article-title>MEF2 negatively regulates learning-induced structural plasticity and memory formation</article-title>. <source/>Nat Neurosci. (<year>2012</year>) <volume>15</volume>:<fpage>1255</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3189</pub-id><pub-id pub-id-type="pmid">22885849</pub-id></mixed-citation>
</ref>
<ref id="B58">
<label>58.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flavell</surname><given-names>SW</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group>. <article-title>Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system</article-title>. <source/>Annu Rev Neurosci. (<year>2008</year>) <volume>31</volume>:<fpage>563</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.neuro.31.060407.125631</pub-id><pub-id pub-id-type="pmid">18558867</pub-id></mixed-citation>
</ref>
<ref id="B59">
<label>59.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tai</surname><given-names>Y</given-names></name><name><surname>Feng</surname><given-names>S</given-names></name><name><surname>Ge</surname><given-names>R</given-names></name><name><surname>Du</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><etal></etal></person-group>. <article-title>TRPC6 channels promote dendritic growth via the CaMKIV-CREB pathway</article-title>. <source/>J Cell Sci. (<year>2008</year>) <volume>121</volume>(<issue>Pt 14</issue>):<fpage>2301</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.026906</pub-id><pub-id pub-id-type="pmid">18559891</pub-id></mixed-citation>
</ref>
<ref id="B60">
<label>60.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flavell</surname><given-names>SW</given-names></name><name><surname>Cowan</surname><given-names>CW</given-names></name><name><surname>Kim</surname><given-names>TK</given-names></name><name><surname>Greer</surname><given-names>PL</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Paradis</surname><given-names>S</given-names></name><etal></etal></person-group>. <article-title>Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number</article-title>. <source/>Science. (<year>2006</year>) <volume>311</volume>:<fpage>1008</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1126/science.1122511</pub-id><pub-id pub-id-type="pmid">16484497</pub-id></mixed-citation>
</ref>
<ref id="B61">
<label>61.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Du</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>K</given-names></name><name><surname>Tai</surname><given-names>Y</given-names></name><name><surname>Yao</surname><given-names>H</given-names></name><name><surname>Jia</surname><given-names>Y</given-names></name><etal></etal></person-group>. <article-title>Critical role of TRPC6 channels in the formation of excitatory synapses</article-title>. <source/>Nat Neurosci. (<year>2008</year>) <volume>11</volume>:<fpage>741</fpage>–<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2127</pub-id><pub-id pub-id-type="pmid">18516035</pub-id></mixed-citation>
</ref>
<ref id="B62">
<label>62.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Bao</surname><given-names>X</given-names></name><etal></etal></person-group>. <article-title>Novel MEF2C point mutations in Chinese patients with Rett (-like) syndrome or non-syndromic intellectual disability: insights into genotype-phenotype correlation</article-title>. <source/>BMC Med Genet. (<year>2018</year>) <volume>19</volume>:<fpage>191</fpage>. <pub-id pub-id-type="doi">10.1186/s12881-018-0699-1</pub-id><pub-id pub-id-type="pmid">30376817</pub-id></mixed-citation>
</ref>
<ref id="B63">
<label>63.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D‘Haene</surname><given-names>E</given-names></name><name><surname>Bar-Yaacov</surname><given-names>R</given-names></name><name><surname>Bariah</surname><given-names>I</given-names></name><name><surname>Vantomme</surname><given-names>L</given-names></name><name><surname>Van Loo</surname><given-names>S</given-names></name><name><surname>Cobos</surname><given-names>FA</given-names></name><etal></etal></person-group>. <article-title>A neuronal enhancer network upstream of MEF2C is compromised in patients with Rett-like characteristics</article-title>. <source/>Hum Mol Genet. (<year>2019</year>) <volume>28</volume>:<fpage>818</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddy393</pub-id><pub-id pub-id-type="pmid">30445463</pub-id></mixed-citation>
</ref>
<ref id="B64">
<label>64.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrow</surname><given-names>EM</given-names></name><name><surname>Yoo</surname><given-names>SY</given-names></name><name><surname>Flavell</surname><given-names>SW</given-names></name><name><surname>Kim</surname><given-names>TK</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Hill</surname><given-names>RS</given-names></name><etal></etal></person-group>. <article-title>Identifying autism loci and genes by tracing recent shared ancestry</article-title>. <source/>Science. (<year>2008</year>) <volume>321</volume>:<fpage>218</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1126/science.1157657</pub-id><pub-id pub-id-type="pmid">18621663</pub-id></mixed-citation>
</ref>
<ref id="B65">
<label>65.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipton</surname><given-names>SA</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Zaremba</surname><given-names>JD</given-names></name><name><surname>McKercher</surname><given-names>SR</given-names></name><name><surname>Cui</surname><given-names>J</given-names></name><name><surname>Kang</surname><given-names>YJ</given-names></name><etal></etal></person-group>. <article-title>Autistic phenotype from MEF2C knockout cells</article-title>. <source/>Science. (<year>2009</year>) <volume>323</volume>:<fpage>208</fpage>. <pub-id pub-id-type="doi">10.1126/science.323.5911.208b</pub-id><pub-id pub-id-type="pmid">19131610</pub-id></mixed-citation>
</ref>
<ref id="B66">
<label>66.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tu</surname><given-names>S</given-names></name><name><surname>Akhtar</surname><given-names>MW</given-names></name><name><surname>Escorihuela</surname><given-names>RM</given-names></name><name><surname>Amador-Arjona</surname><given-names>A</given-names></name><name><surname>Swarup</surname><given-names>V</given-names></name><name><surname>Parker</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism</article-title>. <source/>Nat Commun. (<year>2017</year>) <volume>8</volume>:<fpage>1488</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-017-01563-8</pub-id><pub-id pub-id-type="pmid">29133852</pub-id></mixed-citation>
</ref>
<ref id="B67">
<label>67.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaslavsky</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>WB</given-names></name><name><surname>McCready</surname><given-names>FP</given-names></name><name><surname>Rodrigues</surname><given-names>DC</given-names></name><name><surname>Deneault</surname><given-names>E</given-names></name><name><surname>Loo</surname><given-names>C</given-names></name><etal></etal></person-group>. <article-title>SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons</article-title>. <source/>Nat Neurosci. (<year>2019</year>) <volume>22</volume>:<fpage>556</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-019-0365-8</pub-id><pub-id pub-id-type="pmid">30911184</pub-id></mixed-citation>
</ref>
<ref id="B68">
<label>68.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>KJ</given-names></name><name><surname>Garner</surname><given-names>JP</given-names></name><name><surname>Libove</surname><given-names>RA</given-names></name><name><surname>Hyde</surname><given-names>SA</given-names></name><name><surname>Hornbeak</surname><given-names>KB</given-names></name><name><surname>Carson</surname><given-names>DS</given-names></name><etal></etal></person-group>. <article-title>Plasma oxytocin concentrations and OXTR polymorphisms predict social impairments in children with and without autism spectrum disorder</article-title>. <source/>Proc Natl Acad Sci USA. (<year>2014</year>) <volume>111</volume>:<fpage>12258</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1402236111</pub-id><pub-id pub-id-type="pmid">25092315</pub-id></mixed-citation>
</ref>
<ref id="B69">
<label>69.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Husarova</surname><given-names>VM</given-names></name><name><surname>Lakatosova</surname><given-names>S</given-names></name><name><surname>Pivovarciova</surname><given-names>A</given-names></name><name><surname>Babinska</surname><given-names>K</given-names></name><name><surname>Bakos</surname><given-names>J</given-names></name><name><surname>Durdiakova</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>Plasma oxytocin in children with autism and its correlations with behavioral parameters in children and parents</article-title>. <source/>Psychiatry Investig. (<year>2016</year>) <volume>13</volume>:<fpage>174</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.4306/pi.2016.13.2.174</pub-id><pub-id pub-id-type="pmid">27081377</pub-id></mixed-citation>
</ref>
<ref id="B70">
<label>70.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomova</surname><given-names>A</given-names></name><name><surname>Husarova</surname><given-names>V</given-names></name><name><surname>Lakatosova</surname><given-names>S</given-names></name><name><surname>Bakos</surname><given-names>J</given-names></name><name><surname>Vlkova</surname><given-names>B</given-names></name><name><surname>Babinska</surname><given-names>K</given-names></name><etal></etal></person-group>. <article-title>Gastrointestinal microbiota in children with autism in Slovakia</article-title>. <source/>Physiol Behav. (<year>2015</year>) <volume>138</volume>:<fpage>179</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2014.10.033</pub-id><pub-id pub-id-type="pmid">25446201</pub-id></mixed-citation>
</ref>
<ref id="B71">
<label>71.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>RI</given-names></name><name><surname>Tan</surname><given-names>SW</given-names></name><name><surname>Pean</surname><given-names>CB</given-names></name><name><surname>Roostalu</surname><given-names>U</given-names></name><name><surname>Vivancos</surname><given-names>V</given-names></name><name><surname>Bronda</surname><given-names>K</given-names></name><etal></etal></person-group>. <article-title>MEF2 is an <italic>in vivo</italic> immune-metabolic switch</article-title>. <source/>Cell. (<year>2013</year>) <volume>155</volume>:<fpage>435</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.09.007</pub-id><pub-id pub-id-type="pmid">24075010</pub-id></mixed-citation>
</ref>
<ref id="B72">
<label>72.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharon</surname><given-names>G</given-names></name><name><surname>Sampson</surname><given-names>TR</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name><name><surname>Mazmanian</surname><given-names>SK</given-names></name></person-group>. <article-title>The central nervous system and the gut microbiome</article-title>. <source/>Cell. (<year>2016</year>) <volume>167</volume>:<fpage>915</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.10.027</pub-id><pub-id pub-id-type="pmid">27814521</pub-id></mixed-citation>
</ref>
<ref id="B73">
<label>73.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alaerts</surname><given-names>K</given-names></name><name><surname>Bernaerts</surname><given-names>S</given-names></name><name><surname>Vanaudenaerde</surname><given-names>B</given-names></name><name><surname>Daniels</surname><given-names>N</given-names></name><name><surname>Wenderoth</surname><given-names>N</given-names></name></person-group>. <article-title>Amygdala-hippocampal connectivity is associated with endogenous levels of oxytocin and can be altered by exogenously administered oxytocin in adults with autism</article-title>. <source/>Biol Psychiatry Cogn Neurosci Neuroimaging. (<year>2019</year>) <volume>4</volume>:<fpage>655</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpsc.2019.01.008</pub-id><pub-id pub-id-type="pmid">30846366</pub-id></mixed-citation>
</ref>
<ref id="B74">
<label>74.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Havranek</surname><given-names>T</given-names></name><name><surname>Lestanova</surname><given-names>Z</given-names></name><name><surname>Mravec</surname><given-names>B</given-names></name><name><surname>Strbak</surname><given-names>V</given-names></name><name><surname>Bakos</surname><given-names>J</given-names></name><name><surname>Bacova</surname><given-names>Z</given-names></name></person-group>. <article-title>Oxytocin modulates expression of neuron and glial markers in the rat hippocampus</article-title>. <source/>Folia Biol. (<year>2017</year>) <volume>63</volume>:<fpage>91</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">28805558</pub-id></mixed-citation>
</ref>
<ref id="B75">
<label>75.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lestanova</surname><given-names>Z</given-names></name><name><surname>Puerta</surname><given-names>F</given-names></name><name><surname>Alanazi</surname><given-names>M</given-names></name><name><surname>Bacova</surname><given-names>Z</given-names></name><name><surname>Kiss</surname><given-names>A</given-names></name><name><surname>Castejon</surname><given-names>AM</given-names></name><etal></etal></person-group>. <article-title>Downregulation of oxytocin receptor decreases the length of projections stimulated by retinoic acid in the U-87MG cells</article-title>. <source/>Neurochem Res. (<year>2017</year>) <volume>42</volume>:<fpage>1006</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-016-2133-4</pub-id><pub-id pub-id-type="pmid">27995495</pub-id></mixed-citation>
</ref>
<ref id="B76">
<label>76.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakos</surname><given-names>J</given-names></name><name><surname>Srancikova</surname><given-names>A</given-names></name><name><surname>Havranek</surname><given-names>T</given-names></name><name><surname>Bacova</surname><given-names>Z</given-names></name></person-group>. <article-title>Molecular mechanisms of oxytocin signaling at the synaptic connection</article-title>. <source/>Neural Plast. (<year>2018</year>) <volume>2018</volume>:<fpage>4864107</fpage>. <pub-id pub-id-type="doi">10.1155/2018/4864107</pub-id><pub-id pub-id-type="pmid">30057594</pub-id></mixed-citation>
</ref>
<ref id="B77">
<label>77.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zatkova</surname><given-names>M</given-names></name><name><surname>Reichova</surname><given-names>A</given-names></name><name><surname>Bacova</surname><given-names>Z</given-names></name><name><surname>Strbak</surname><given-names>V</given-names></name><name><surname>Kiss</surname><given-names>A</given-names></name><name><surname>Bakos</surname><given-names>J</given-names></name></person-group>. <article-title>Neurite outgrowth stimulated by oxytocin is modulated by inhibition of the calcium voltage-gated channels</article-title>. <source/>Cell Mol Neurobiol. (<year>2018</year>) <volume>38</volume>:<fpage>371</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/s10571-017-0503-3</pub-id><pub-id pub-id-type="pmid">28493233</pub-id></mixed-citation>
</ref>
<ref id="B78">
<label>78.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zatkova</surname><given-names>M</given-names></name><name><surname>Reichova</surname><given-names>A</given-names></name><name><surname>Bacova</surname><given-names>Z</given-names></name><name><surname>Bakos</surname><given-names>J</given-names></name></person-group>. <article-title>Activation of the oxytocin receptor modulates the expression of synaptic adhesion molecules in a cell-specific manner</article-title>. <source/>J Mol Neurosci. (<year>2019</year>) <volume>68</volume>:<fpage>171</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-019-01296-x</pub-id><pub-id pub-id-type="pmid">30888622</pub-id></mixed-citation>
</ref>
<ref id="B79">
<label>79.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brusco</surname><given-names>J</given-names></name><name><surname>Haas</surname><given-names>K</given-names></name></person-group>. <article-title>Interactions between mitochondria and the transcription factor myocyte enhancer factor 2 (MEF2) regulate neuronal structural and functional plasticity and metaplasticity</article-title>. <source/>J Physiol. (<year>2015</year>) <volume>593</volume>:<fpage>3471</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2014.282459</pub-id><pub-id pub-id-type="pmid">25581818</pub-id></mixed-citation>
</ref>
<ref id="B80">
<label>80.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grinevich</surname><given-names>V</given-names></name><name><surname>Knobloch-Bollmann</surname><given-names>HS</given-names></name><name><surname>Eliava</surname><given-names>M</given-names></name><name><surname>Busnelli</surname><given-names>M</given-names></name><name><surname>Chini</surname><given-names>B</given-names></name></person-group>. <article-title>Assembling the puzzle: pathways of oxytocin signaling in the brain</article-title>. <source/>Biol Psychiatry. (<year>2016</year>) <volume>79</volume>:<fpage>155</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2015.04.013</pub-id><pub-id pub-id-type="pmid">26001309</pub-id></mixed-citation>
</ref>
<ref id="B81">
<label>81.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasan</surname><given-names>MT</given-names></name><name><surname>Althammer</surname><given-names>F</given-names></name><name><surname>Silva da Gouveia</surname><given-names>M</given-names></name><name><surname>Goyon</surname><given-names>S</given-names></name><name><surname>Eliava</surname><given-names>M</given-names></name><name><surname>Lefevre</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>A fear memory engram and its plasticity in the hypothalamic oxytocin system</article-title>. <source/>Neuron. (<year>2019</year>) <volume>103</volume>:<fpage>133</fpage>–<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2019.04.029</pub-id><pub-id pub-id-type="pmid">31104950</pub-id></mixed-citation>
</ref>
<ref id="B82">
<label>82.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shalizi</surname><given-names>A</given-names></name><name><surname>Gaudilliere</surname><given-names>B</given-names></name><name><surname>Yuan</surname><given-names>Z</given-names></name><name><surname>Stegmuller</surname><given-names>J</given-names></name><name><surname>Shirogane</surname><given-names>T</given-names></name><name><surname>Ge</surname><given-names>Q</given-names></name><etal></etal></person-group>. <article-title>A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation</article-title>. <source/>Science. (<year>2006</year>) <volume>311</volume>:<fpage>1012</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1126/science.1122513</pub-id><pub-id pub-id-type="pmid">16484498</pub-id></mixed-citation>
</ref>
<ref id="B83">
<label>83.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>NP</given-names></name><name><surname>Wilkerson</surname><given-names>JR</given-names></name><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>Huber</surname><given-names>KM</given-names></name></person-group>. <article-title>FMRP-dependent Mdm2 dephosphorylation is required for MEF2-induced synapse elimination</article-title>. <source/>Hum Mol Genet. (<year>2017</year>) <volume>26</volume>:<fpage>293</fpage>–<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddw386</pub-id><pub-id pub-id-type="pmid">28025327</pub-id></mixed-citation>
</ref>
<ref id="B84">
<label>84.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>She</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Shepherd</surname><given-names>K</given-names></name><name><surname>Smith</surname><given-names>Y</given-names></name><name><surname>Miller</surname><given-names>G</given-names></name><name><surname>Testa</surname><given-names>C</given-names></name><etal></etal></person-group>. <article-title>Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients</article-title>. <source/>J Clin Invest. (<year>2011</year>) <volume>121</volume>:<fpage>930</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1172/JCI43871</pub-id><pub-id pub-id-type="pmid">21393861</pub-id></mixed-citation>
</ref>
<ref id="B85">
<label>85.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flavell</surname><given-names>SW</given-names></name><name><surname>Kim</surname><given-names>TK</given-names></name><name><surname>Gray</surname><given-names>JM</given-names></name><name><surname>Harmin</surname><given-names>DA</given-names></name><name><surname>Hemberg</surname><given-names>M</given-names></name><name><surname>Hong</surname><given-names>EJ</given-names></name><etal></etal></person-group>. <article-title>Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection</article-title>. <source/>Neuron. (<year>2008</year>) <volume>60</volume>:<fpage>1022</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2008.11.029</pub-id><pub-id pub-id-type="pmid">19109909</pub-id></mixed-citation>
</ref>
<ref id="B86">
<label>86.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weisman</surname><given-names>O</given-names></name><name><surname>Zagoory-Sharon</surname><given-names>O</given-names></name><name><surname>Feldman</surname><given-names>R</given-names></name></person-group>. <article-title>Oxytocin administration alters HPA reactivity in the context of parent-infant interaction</article-title>. <source/>Eur Neuropsychopharmacol. (<year>2013</year>) <volume>23</volume>:<fpage>1724</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.euroneuro.2013.06.006</pub-id><pub-id pub-id-type="pmid">23906646</pub-id></mixed-citation>
</ref>
<ref id="B87">
<label>87.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Qi</surname><given-names>S</given-names></name><name><surname>Becker</surname><given-names>B</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>S</given-names></name><name><surname>Gong</surname><given-names>Q</given-names></name><etal></etal></person-group>. <article-title>Oxytocin selectively facilitates learning with social feedback and increases activity and functional connectivity in emotional memory and reward processing regions</article-title>. <source/>Hum Brain Mapp. (<year>2015</year>) <volume>36</volume>:<fpage>2132</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1002/hbm.22760</pub-id><pub-id pub-id-type="pmid">25664702</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>